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Live Case Demonstration of
Interventional Cardiology
Procedures
Is It Really Safe?*
John B. Simpson, MD, PHD
Redwood City, California
In this issue of JACC: Cardiovascular Interventions, Eliyahu
et al. (1) are certainly attempting to address a very important
issue confronting the interventional community as we all try
to maximize patient safety while teaching techniques re-
quired for new and sometimes more complex technologies.
The authors summarize their own cumulative “live demon-
stration” outcomes spanning 15 years, 101 patients, and 5
different interventional procedures, and do a very good job of
capturing all the technical issues that differentiate a live from
a routine case. They also describe their study design and
primary safety and efficacy endpoints as well as a com-
parison of their study group to a matched control group.
See pages 215 and 225
In summary, they determine that “for patients who are carefully
selected and treated by an experienced team, the stressful condi-
tions that are associated with live case transmissions do not
jeopardize patient safety and procedural efficiency.” On the basis of
their careful analysis of their patients, I believe the authors have
come to the correct conclusion, and perhaps I feel reassured
because it agrees with my perspective developed over more than a
few years in the space.
That being said, all my personal experiences with live cases
have not been as favorable as that of the authors. As they have
described, there seem to be countless concerns with regard to
live cases, but 2 in particular stand out in my mind. The first is
patient selection, of course, and the second is a combination of
operator experience and sometimes, almost as important,
operator comfort with the live transmission environment. I
know we all try to do representative cases during a live telecast, but
the bias derived from always wanting the safest and best outcome
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of Avinger Inc.for the patient inevitably drives me toward avoiding cases that
appear to be the most difficult. It is unrealistic also not to
acknowledge that most interventionists are fairly normal human
beings and have the same fear of public failure and embarrassment
that is seen in all segments of our society. Any interventionist who
says these issues are of no concern is suspect in my mind. I actually
think the fear of failure and embarrassment is that element that
most ensures the patient’s safety. I have yet to see or participate in
a live transmission where none of the physicians seemed to care
about the outcome.
The risk could then be that the operator is so afraid to fail
that he or she makes mistakes in judgment or technique that
cause patient harm. I think this occurrence is truly rare, and I
am not sure I have seen it. More often than not, a case that is
not likely to work is terminated with the plan to try again later
as the technology gets better, or in the coronary space, proceed
with routine bypass surgery. Some cardiologists do consider
converting to bypass a failure, but that is a topic for discussion
in a different forum. The authors also nicely summarize the
role of the Food and Drug Administration in providing
oversight over live cases in particular as it relates to using
unapproved devices. My hope is that government involvement
in live case oversight is approached carefully and thoughtfully,
and not in a way that interferes with the educational value of
this format; which I remain convinced is one of the most
effective available to the interventional community.
I understand the difficult task of the writing committee
mentioned by the authors that led to the conclusion: “After
evaluating the pros and cons of live case demonstrations and
the available data, the writing committee cannot determine if
the educational benefits of live case demonstrations outweigh
any potential negative consequences.” I have had the rare
privilege to participate in and watch the growth and develop-
ment of this teaching modality since angioplasty was intro-
duced by Andreas Gruentzig, MD, over 30 years ago. Given
my experiences, I cannot imagine a better way to teach
interventional techniques, and I perceive the value to far
outweigh any potential negative consequences. I remain a
strong believer that it is the ubiquitous fear of failure that
makes it safe for the patient and valuable for the physician.
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